Conditions: Ulcerative Colitis
Keywords: treatment of ulcerative colitis; CP 690 550
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 195
Healthy volunteers: no

Brief summary:
The hypothesis of the study is that at least one dose of CP 690 550 is superior to placebo (inactive drug) in inducing remission in patients with moderate to severe ulcerative colitis.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None arm 5: None

Interventions: intervention 1: CP- 690 550 intervention 2: CP- 690 550 intervention 3: CP- 690 550 intervention 4: CP- 690 550 intervention 5: placebo
Intervention descriptions: intervention 1: Administration via oral route twice daily for the duration of treatment intervention 2: Administration via oral route twice daily for the duration of treatment intervention 3: Administration via oral route twice daily for the duration of treatment intervention 4: Administration via oral route twice daily for the duration of treatment intervention 5: Administration via oral route twice daily for the duration of treatment

Protocol document: